Drug Shortage Report for MOBICOX

Last updated on 2017-05-10 History
Report ID 4323
Drug Identification Number 02242785
Brand name MOBICOX
Common or Proper name Mobicox
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) MELOXICAM
Strength(s) 7.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code M01AC
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-04-03
Actual start date
Estimated end date 2017-05-19
Actual end date 2017-05-09
Shortage status Resolved
Updated date 2017-05-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-05-10 English Compare
v9 2017-05-09 French Compare
v8 2017-05-09 English Compare
v7 2017-05-05 French Compare
v6 2017-05-05 English Compare
v5 2017-05-01 French Compare
v4 2017-05-01 English Compare
v3 2017-04-04 English Compare
v2 2017-03-25 French Compare
v1 2017-03-25 English Compare

Showing 1 to 10 of 10